Condition: Infection Post Op · Hysterectomy · Antibiotics · Sponsor: Helsinki University Central Hospital
During hysterectomy bacteria may enter into the peritoneal cavity through vaginal opening and contaminate the healing tissues. The risk for deep infection after hysterectomy is about 5%. By reducing post-hysterectomy infections, it is possible to reduce individual burden of disease in addition to the direct and indirect financial costs. This study primary aim is to assess if prophylactic preoperative use of azithromycin in addition to generally used cefuroxime decreases post-hysterectomy infections as compared to cefuroxime only prophylaxis during 30 days after hysterectomy. Secondary aim is to assess if there is change in post-hysterectomy superficial infections, urinary tract infections, or post-operative fever between the cohorts and to report possible side-effects of the used antibiotics. In addition, the study finds out a possible role of bacterial vaginosis and microbiome n post-hysterectomy infections.
This description comes directly from the study's public registry record.
Päivi K Rahkola-Soisalo, Adj prof,MD · +358504270411 · paivi.rahkola-soisalo@hus.fi
Ninja Savonius, MD · +358503466986 · ninja.savonius@hus.fi
Always discuss trial participation with your own doctor first.
| Helsinki University Central Hospital | Helsinki, Finland | Recruiting |
| Jyväskylä Central Hospital | Jyväskylä, Finland | Recruiting |
| Kuopio University Central Hospital | Kuopio, Finland | Recruiting |
| Oulu University Central Hospital | Oulu, Finland | Recruiting |
| Tampere University Central Hospital | Tampere, Finland | Recruiting |
| Turku University Central Hospital | Turku, Finland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05337566